Maravai LifeSciences Inc... (MRVI)
NASDAQ: MRVI
· Real-Time Price · USD
3.13
0.16 (5.39%)
At close: Oct 03, 2025, 2:29 PM
5.39% (1D)
| Bid | 3.13 |
| Market Cap | 851.94M |
| Revenue (ttm) | 215.85M |
| Net Income (ttm) | -194.72M |
| EPS (ttm) | -1.37 |
| PE Ratio (ttm) | -2.29 |
| Forward PE | -14.95 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 3.14 |
| Volume | 1,446,452 |
| Avg. Volume (20D) | 1,417,238 |
| Open | 2.94 |
| Previous Close | 2.97 |
| Day's Range | 2.94 - 3.30 |
| 52-Week Range | 1.67 - 8.54 |
| Beta | 0.29 |
| Ex-Dividend Date | n/a |
About MRVI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MRVI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MRVI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsMaravai LifeSciences Inc. is scheduled to release its earnings on
Nov 6, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+30.58%
Maravai LifeSciences Holdings shares are trading h...
Unlock content with
Pro Subscription
1 month ago
-6.36%
Maravai LifeSciences Holdings shares are trading higher. The company reported Q2 financial results.
1 month ago · seekingalpha.com
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2025 Earnings Call TranscriptMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q2 2025 Earnings Conference Call August 11, 2025 5:00 PM ET Company Participants Bernd Brust - CEO & Director Debra Hart - Senior Director of Investo...
